MedPath

Sodium Chloride

0.9% Sodium Chloride Injection, USP in FLEBOFLEX and FLEBOFLEX LUER Plastic Container

Approved
Approval ID

4d0bfd28-460a-48ba-bd17-cf75e56d62f4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2023

Manufacturers
FDA

SOLA Pharmaceuticals, LLC

DUNS: 080121345

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70512-841
Application NumberANDA207956
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 21, 2023
FDA Product Classification

INGREDIENTS (2)

Sodium ChlorideActive
Quantity: 9 g in 1000 mL
Code: 451W47IQ8X
Classification: ACTIB
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Chloride - FDA Drug Approval Details